External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort

BACKGROUND: External validation of risk calculators (RCs) is necessary to determine their clinical applicability beyond the setting in which these were developed. OBJECTIVE: To assess the performance of the Rotterdam Prostate Cancer RC (RPCRC) and the Prostate Biopsy Collaborative Group RC (PBCG-RC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra Engel, Jan, Palsdottir, Thorgerdur, Ankerst, Donna, Remmers, Sebastiaan, Mortezavi, Ashkan, Chellappa, Venkatesh, Egevad, Lars, Grönberg, Henrik, Eklund, Martin, Nordström, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257644/
https://www.ncbi.nlm.nih.gov/pubmed/35813248
http://dx.doi.org/10.1016/j.euros.2022.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257644/
https://www.ncbi.nlm.nih.gov/pubmed/35813248
http://dx.doi.org/10.1016/j.euros.2022.04.010

Ejemplares similares